ClinicalTrials.gg
DrugBiological

Brodalumab clinical trials

Also written AMG 827, Siliq and KHK4827.

studies test it
44
open now
1
in phase 3
14
first study started
2008

How each study uses brodalumab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the brodalumab studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
15 Feb 2017 · SILIQ · BLA 761032 (FDA, Drugs@FDA)
European Union
17 Jul 2017 · Kyntheum · EMEA/H/C/003959 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Brodalumab
23
Kyntheum®
5
210 mg brodalumab
5
140 mg brodalumab
5

Brand

Siliq
8

Development codes

AMG 827
12
KHK4827
8

Studies by the year they started

44 studies that test it; most in 2012 (5)

Studies that test brodalumab, by start year
YearStudies
20081
20092
20104
20113
20125
20134
20144
20161
20175
20181
20194
20205
20212
20222
20251

By phase

A phase 1/2 study counts in both.

Early Phase 1
3
Phase 1
6
Phase 2
12
Phase 3
14
Phase 4
10

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 35 · Other 9

Bausch Health Americas, Inc. (11) · Kyowa Kirin Co., Ltd. (11) · Amgen (7) · LEO Pharma (4) · Rockefeller University (3) · Radboud University Medical Center (1) · Kyowa Kirin Korea Co., Ltd. (1) · Icahn School of Medicine at Mount Sinai (1)

Often tested with

Tested in the same studies.

Secukinumab (1) · Ixekizumab (1) · Guselkumab (1) · Risankizumab (1) · Tildrakizumab (1) · Bimekizumab (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test brodalumab.

Studies

Open first, then newest update. How each study uses brodalumab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 44

See all 44 studies that test brodalumab →

Codes

What other systems call brodalumab · ClinicalTrials.gg INT006025

  • MeSH (NLM) C571216brodalumabConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 6ZA31Y954ZBRODALUMABConfirmed FDA, NLM, Wikidata
  • RxNorm 1872251Confirmed FDA, Wikidata
  • Wikidata Q4972934brodalumabConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C166971BrodalumabOne source FDA
  • DrugBank DB11776One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.